Part of the book series:Current Topics in Behavioral Neurosciences ((CTBN,volume 58))
Abstract
Neurodegenerative diseases are increasingly recognised to be an important cause of brain disorders, particularly in late age. Associated with a wide range of pathologies, they lead to progressive loss of neurons in different regions of the nervous system. Although anhedonia is common in a variety of neurodegenerative diseases, to date it has not been extensively studied in most of these conditions. Here we review the current literature on studies assessing the association between anhedonia and neurodegenerative diseases including Parkinson’s Disease, Dementia with Lewy Bodies, Parkinson’s Plus Syndromes, Alzheimer’s Disease, Vascular Dementia, Frontotemporal Dementia, Amyotrophic Lateral Sclerosis and Huntington’s Disease. Much of the research has been conducted in Parkinson’s disease where it is evident that there are strong links between apathy (loss of motivation) and anhedonia, although the two syndromes can be dissociated. Intriguingly, drugs that improve apathy can also lead to amelioration of anhedonia in some cases. Overlaps between the two syndromes may also exist across other neurodegenerative conditions, including Frontotemporal Dementia in which imaging has revealed atrophy of both common brain regions associated with anhedonia and apathy, as well as a set of unique brain regions associated with anhedonia. A transdiagnostic perspective might be helpful to investigate whether a common network of brain regions is dysfunctional with anhedonia across neurodegenerative conditions.
This is a preview of subscription content,log in via an institution to check access.
Access this chapter
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
- Chapter
- JPY 3498
- Price includes VAT (Japan)
- eBook
- JPY 22879
- Price includes VAT (Japan)
- Softcover Book
- JPY 28599
- Price includes VAT (Japan)
- Hardcover Book
- JPY 28599
- Price includes VAT (Japan)
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aalten P, Verhey FRJ, Boziki M et al (2007) Neuropsychiatric syndromes in dementia. Dement Geriatr Cogn Disord 24:457–463
Abrahams S, Leigh PN, Goldstein LH (2005) Cognitive change in ALS: a prospective study. Neurology 64:1222–1226
Ang Y-S, Lockwood P, Apps MAJ et al (2017) Distinct subtypes of apathy revealed by the apathy motivation index. PLoS One 12:e0169938
Ang YS, Lockwood PL, Kienast A et al (2018) Differential impact of behavioral, social, and emotional apathy on Parkinson’s disease. Ann Clin Transl Neurol 5:1286–1291
Antosik-Wójcińska A, Święcicki Ł, Dominiak M et al (2017) Impact of STN-DBS on mood, drive, anhedonia and risk of psychiatric side-effects in the population of PD patients. J Neurol Sci 375:342–347
Armstrong MJ, McFarland N (2019) Recognizing and treating atypical Parkinson disorders. Handb Clin Neurol 167:301–320
Assogna F, Cravello L, Caltagirone C, Spalletta G (2011) Anhedonia in Parkinson’s disease: a systematic review of the literature. Mov Disord 26:1825–1834
Assogna F, Pellicano C, Cravello L et al (2019) Alexithymia and anhedonia in early Richardson’s syndrome and progressive supranuclear palsy with predominant parkinsonism. Brain Behav 9:3–9
Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573–580
Berridge KC, Kringelbach ML (2013) Neuroscience of affect: brain mechanisms of pleasure and displeasure. Curr Opin Neurobiol 23:294–303
Berridge KC, Kringelbach ML (2015) Pleasure systems in the brain. Neuron 86:646–664
Berridge KC, Robinson TE (2003) Parsing reward. Trends Neurosci 26:507–513
Blass DM, Rabins PV (2009) Depression in frontotemporal dementia. Psychosomatics 50:239–247
Bungener C, Piquard A, Pradat PF et al (2005) Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Mot Neuron Disord 6:221–225
Chapman LJ, Chapman JP, Raulin ML (1976) Scales for physical and social anhedonia. J Abnorm Psychol 85:374–382
Chiu PY, Wang CW, Tsai CT et al (2017) Depression in dementia with Lewy bodies: a comparison with Alzheimer’s disease. PLoS One 12:e0179399
Dujardin K, Langlois C, Plomhause L et al (2014) Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms. Mov Disord 29:1796–1801
Elman LB, Grossman M (2007) Neuropsychiatric features of amyotrophic lateral sclerosis. NeuroRehabilitation 22:425–429
Feigin VL, Vos T, Nichols E et al (2020) The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 19:255–265
Fujiwara S, Kimura F, Hosokawa T et al (2011) Anhedonia in Japanese patients with Parkinson’s disease. Geriatr Gerontol Int 11:275–281
Hayes CJ, Stevenson RJ, Coltheart M (2007) Disgust and Huntington’s disease. Neuropsychologia 45:1135–1151
Hodges JR, Piguet O (2018) Progress and challenges in frontotemporal dementia research: a 20-year review. J Alzheimers Dis 62:1467–1480
Husain M, Roiser JP (2018) Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci 19:470–484
Isella V, Iurlaro S, Piolti R et al (2003) Physical anhedonia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:1308–1311
Jordan LL, Zahodne LB, Okun MS, Bowers D (2013) Hedonic and behavioral deficits associated with apathy in Parkinson’s disease: potential treatment implications. Mov Disord 28:1301–1304
Kaji Y, Hirata K (2011) Apathy and anhedonia in Parkinson’s disease. ISRN Neurol 2011:219427
Klein D (1984) Depression and anhedonia. In: Clark DC, Fawcett J (eds) Anhedonia and affect deficit states. PMA Publishing, New York, pp 1–14
Lansdall CJ, Coyle-Gilchrist ITS, Jones PS et al (2017) Apathy and impulsivity in frontotemporal lobar degeneration syndromes. Brain 140:1792–1807
Lavretsky H, Zheng L, Weiner MW et al (2008) The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry 23:1040–1050
Lee JR, Suh SW, Han JW et al (2019) Anhedonia and dysphoria are differentially associated with the risk of dementia in the cognitively normal elderly individuals: a prospective cohort study. Psychiatry Investig 16:575–580
Lemke MR (2005) Anhedonia, depression, and motor functioning in Parkinson’s disease during treatment with pramipexole. J Neuropsychiatry Clin Neurosci 17:214–220
Lemke MR, Brecht HM, Koester J et al (2005) Anhedonia, depression, and motor functioning in Parkinson’s disease during treatment with pramipexole. J Neuropsychiatry Clin Neurosci 17:214–220
Lemke MR, Brecht HM, Koester J, Reichmann H (2006) Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson’s disease. J Neurol Sci 248:266–270
Levy R, Dubois B (2006) Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 16:916–928
Loas G, Duru C, Godefroy O, Krystkowiak P (2014) Hedonic deficits in Parkinson’s disease: is consummatory anhedonia specific? Front Neurol 5:24
Lopez OL, Becker JT, Sweet RA et al (2003) Psychiatric symptoms vary with the severity of dementia in probable Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 15:346–353
Lopez OL, Becker JT, Sweet RA (2005) Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase 11:65–71
MacDonald M (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243–254
Martínez HR, Escamilla-Ocañas CE, Hernández-Torre M (2018) Non-motor neurological symptoms in patients with amyotrophic lateral sclerosis. Neurologia 33:474–476
Marxreiter F, Mrochen A, Kozay C et al (2016) G3 hedonic olfaction in huntington’s disease. J Neurol Neurosurg Psychiatry 87:A55–A55
Massimo L, Powers JP, Evans LK et al (2015) Apathy in frontotemporal degeneration: neuroanatomical evidence of impaired goal-directed behavior. Front Hum Neurosci 9:611
Matsui K, Tachibana H, Yamanishi T et al (2013) Clinical correlates of anhedonia in patients with Parkinson’s disease. Clin Neurol Neurosurg 115:2524–2527
McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88–100
Mendez MF, Anderson E, Shapira JS (2005) An investigation of moral judgement in frontotemporal dementia. Cogn Behav Neurol 18:193–197
Miura S, Kida H, Nakajima J et al (2012) Anhedonia in Japanese patients with Parkinson’s disease: analysis using the Snaith-Hamilton pleasure scale. Clin Neurol Neurosurg 114:352–355
Mrochen A, Marxreiter F, Kohl Z et al (2016) From sweet to sweat: hedonic olfactory range is impaired in Parkinson’s disease. Park Relat Disord 22:9–14
Nagayama H, Kubo S, Hatano T et al (2012) Validity and reliability assessment of a Japanese version of the Snaith-Hamilton pleasure scale. Intern Med 51:865–869
Nagayama H, Maeda T, Uchiyama T et al (2017) Anhedonia and its correlation with clinical aspects in Parkinson’s disease. J Neurol Sci 372:403–407
Nagayama H, Kano O, Murakami H et al (2019) Effect of istradefylline on mood disorders in Parkinson’s disease. J Neurol Sci 396:78–83
Natta LE, Melrose RJ, Harwood DG, Sultzer DL (2013) An examination of anhedonia separate from depression in Alzheimer’s disease: a preliminary study. Am J Geriatr Psychiatry 21:S78–S79
Pluck GC, Brown RG (2002) Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73:636–642
Pomponi M, Loria G, Salvati S et al (2014) DHA effects in Parkinson disease depression. Basal Ganglia 4:61–66
Rabkin JG, Albert SM, Del BML et al (2005) Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 65:62–67
Reichman WE, Coyne AC (1995) Depressive symptoms in Alzheimer’s disease and multi-infarct dementia. J Geriatr Psychiatry Neurol 8:96–99
Ribot T (1896) La Psychologie des sentiment [The psychology of feelings]. Felix Alcan, Paris
Rockwell E, Choure J, Galasko D et al (2000) Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry 15:819–823
Santangelo G, Morgante L, Savica R et al (2009a) Anhedonia and cognitive impairment in Parkinson’s disease: Italian validation of the Snaith-Hamilton pleasure scale and its application in the clinical routine practice during the PRIAMO study. Park Relat Disord 15:576–581
Santangelo G, Vitale C, Trojano L et al (2009b) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256:632–638
Saz P, López-Antón R, Dewey ME et al (2009) Prevalence and implications of psychopathological non-cognitive symptoms in dementia. Acta Psychiatr Scand 119:107–116
Shaw SR, El-Omar H, Ramanan S et al (2021a) Anhedonia in semantic dementia—exploring right hemispheric contributions to the loss of pleasure. Brain Sci 11:998
Shaw SR, El-Omar H, Roquet D et al (2021b) Uncovering the prevalence and neural substrates of anhedonia in frontotemporal dementia. Brain 144:1551–1564
Snaith RP, Hamilton M, Morley S et al (1995) A scale for the assessment of hedonic tone the Snaith–Hamilton pleasure scale. Br J Psychiatry 167:99–103
Solla P, Cannas A, Mulas CS et al (2014) Association between fatigue and other motor and non-motor symptoms in Parkinson’s disease patients. J Neurol 261:382–391
Spalletta G, Fagioli S, Meco G et al (2013) Hedonic tone and its mood and cognitive correlates in Parkinson’s disease. Depress Anxiety 30:85–91
Starkstein SE, Brockman S (2011) Apathy and Parkinson’s disease. Curr Treat Options Neurol 13:267–273
ter Telgte A, van Leijsen EMC, Wiegertjes K et al (2018) Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol 14:387–398
Thobois S, Lhommée E, Klinger H et al (2013) Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 136:1568–1577
Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35:537–555
Trøstheim M, Eikemo M, Meir R et al (2020) Assessment of anhedonia in adults with and without mental illness: a systematic review and meta-analysis. JAMA Netw Open 3:e2013233
van der Flier WM, Skoog I, Schneider JA et al (2018) Vascular cognitive impairment. Nat Rev Dis Prim 4:1–16
van Duijn E, Craufurd D, Hubers AAM et al (2014) Neuropsychiatric symptoms in a European Huntington’s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 85:1411–1418
Walker FO (2007) Huntington’s disease. Lancet 369:218–228
Whitton AE, Treadway MT, Pizzagalli DA (2015) Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 28:7–12
Witt K, Daniels C, Herzog J et al (2006) Differential effects of l-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 18:397–401
Zhao QF, Tan L, Wang HF et al (2016) The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord 190:264–271
Acknowledgments
This work was funded by The Wellcome Trust and NIHR Oxford Biomedical Research Centre.
Author information
Authors and Affiliations
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
Vicky Turner & Masud Husain
- Vicky Turner
You can also search for this author inPubMed Google Scholar
- Masud Husain
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toMasud Husain.
Editor information
Editors and Affiliations
Harvard Medical School and McLean Hospital, Belmont, MA, USA
Diego A. Pizzagalli
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Turner, V., Husain, M. (2022). Anhedonia in Neurodegenerative Diseases. In: Pizzagalli, D.A. (eds) Anhedonia: Preclinical, Translational, and Clinical Integration. Current Topics in Behavioral Neurosciences, vol 58. Springer, Cham. https://doi.org/10.1007/7854_2022_352
Download citation
Published:
Publisher Name:Springer, Cham
Print ISBN:978-3-031-09682-2
Online ISBN:978-3-031-09683-9
eBook Packages:Biomedical and Life SciencesBiomedical and Life Sciences (R0)
Share this chapter
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative